Conference Reports for NaTaP

EASL - The International Liver Congress 2015 50th annual Meeting of the European association for the Study of the Liver Vienna, austria  april 22-26 Back

Safety and Efficacy of Sofosbuvir-Containing Regimens in Hepatitis C Infected Patients with Reduced Renal Function: Real-World Experience from HCV-TARGET       Reported by Jules Levin EASL 2015 April 22-26 Vienna Austria   V Saxena, FM Koraishy, M Sise, JK Lim, RT Chung, A Liapakis, DR Nelson, M Schmidt, MW Fried, N Terrault for the HCV-TARGET Study Group